A new immunotherapeutic agent for children and adolescents with advanced lymphoma

It establishes a new standard treatment with an improved cure rate for children with advanced non-Hodgkin lymphoma, mainly Burkitt lymphoma.

Besponsa ‘More Effective’ at Driving Remission for Pediatric B-ALL

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

Researchers turn back the clock on cancer cells to offer new treatment paradigm

Study successfully mimics complex neuroblastoma vasculature on a chip to explore treatments

Longer exclusive breastfeeding may lower risk for childhood hematologic cancers

Predicting Infection Risk in Childhood Cancer

Researchers find genetic variant contributing to disparities in childhood leukemia risk

Chemotherapy cured my cancer. Years later it likely gave me heart disease.

How Cancer Can Shape Young Patients’ Sense of Identity

Promoting Cardiovascular Health in Adult Survivors of Childhood Cancers